The earnings call reflects strong performance in Ohio, with significant revenue growth and improved EBITDA margins. However, challenges in the Arizona market and a decline in wholesale sales present hurdles. Overall, the positive growth in Ohio and operational improvements slightly outweigh the issues faced in Arizona.
Company Guidance
During the Vext Science Second Quarter 2025 Financial Results Conference Call, the company reported robust growth metrics, emphasizing disciplined execution and efficient capital allocation. Revenue increased by 59% year-over-year to $13.4 million, while adjusted EBITDA rose by $3 million to $4.1 million, resulting in a 30% adjusted EBITDA margin. Operating cash flow reached $4.2 million, marking a significant turnaround from a negative $0.6 million in the same quarter of 2024. The company highlighted its strategic expansion in Ohio, with consolidated retail sales in the state growing 86% sequentially, underpinned by new dispensaries and a successful drive-thru model. In contrast, despite a 13.7% decline in Arizona's statewide retail sales, Vext's Arizona sales only decreased by 0.3% year-over-year, showcasing their effective cost management and operational discipline. Vext plans to continue capitalizing on the growing Ohio market, aiming to convert top-line growth into free cash flow while maintaining a strong balance sheet.
Record Revenue and Growth
Revenue grew 59% year-over-year to $13.4 million in Q2 2025, compared to $8.4 million in Q2 2024, driven by expansion in Ohio.
Strong Performance in Ohio
Ohio retail sales grew 86% sequentially during the second quarter. The addition of drive-thrus and new dispensaries contributed to increasing customer traffic.
Adjusted EBITDA Increase
Adjusted EBITDA increased by $3 million to $4.1 million, with a 30% adjusted EBITDA margin, reflecting top-line growth and disciplined cost management.
Operating Cash Flow Improvement
Operating cash flow reached $4.2 million in Q2 2025, compared to negative $0.6 million in Q2 2024.
Vext Science (VEXTF) Earnings, Revenues Date & History
The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
VEXTF Earnings-Related Price Changes
Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Aug 20, 2025
$0.17
$0.20
+17.65%
May 21, 2025
$0.08
$0.08
0.00%
Mar 31, 2025
$0.13
$0.12
-7.69%
Nov 21, 2024
$0.14
$0.14
0.00%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Vext Science (VEXTF) report earnings?
Vext Science (VEXTF) is schdueled to report earning on Dec 02, 2025, TBA (Confirmed).
What is Vext Science (VEXTF) earnings time?
Vext Science (VEXTF) earnings time is at Dec 02, 2025, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.